Tianmushan Pharmaceutical’s health products revenue reached 9.61 million yuan
date：2018-04-20
browse：（884）
Keyword：
In 2017, Tianmushan Pharmaceutical (600671) achieved operating revenue of 176 million yuan, an increase of 42.56% year-on-year,and net profit of 8.1416 million yuan, a year-on-year increase of 568.89%. The sales of health products segment was 9.61 million yuan, with an year-on-year increase of 17.7%
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
